IL126548A - Pharmaceutical preparations that suppress the immune system containing aspirochlorine or its 9-chlorine derivative - Google Patents

Pharmaceutical preparations that suppress the immune system containing aspirochlorine or its 9-chlorine derivative

Info

Publication number
IL126548A
IL126548A IL12654897A IL12654897A IL126548A IL 126548 A IL126548 A IL 126548A IL 12654897 A IL12654897 A IL 12654897A IL 12654897 A IL12654897 A IL 12654897A IL 126548 A IL126548 A IL 126548A
Authority
IL
Israel
Prior art keywords
compound
cells
formula
useful
immunosuppressive
Prior art date
Application number
IL12654897A
Other languages
English (en)
Hebrew (he)
Other versions
IL126548A0 (en
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of IL126548A0 publication Critical patent/IL126548A0/xx
Publication of IL126548A publication Critical patent/IL126548A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12654897A 1996-05-03 1997-04-23 Pharmaceutical preparations that suppress the immune system containing aspirochlorine or its 9-chlorine derivative IL126548A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96106991 1996-05-03
PCT/EP1997/002049 WO1997041862A1 (en) 1996-05-03 1997-04-23 Use of aspirochlorine or derivatives thereof as immunosuppressive agents

Publications (2)

Publication Number Publication Date
IL126548A0 IL126548A0 (en) 1999-08-17
IL126548A true IL126548A (en) 2002-02-10

Family

ID=8222742

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12654897A IL126548A (en) 1996-05-03 1997-04-23 Pharmaceutical preparations that suppress the immune system containing aspirochlorine or its 9-chlorine derivative

Country Status (13)

Country Link
US (1) US6133254A (de)
EP (1) EP0914129B1 (de)
JP (1) JP4287908B2 (de)
KR (1) KR100439928B1 (de)
AT (1) ATE209493T1 (de)
AU (1) AU705290B2 (de)
CA (1) CA2253635C (de)
DE (1) DE69708645T2 (de)
DK (1) DK0914129T3 (de)
ES (1) ES2163763T3 (de)
IL (1) IL126548A (de)
PT (1) PT914129E (de)
WO (1) WO1997041862A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007287928A (ja) 2006-04-17 2007-11-01 Nec Electronics Corp 半導体集積回路およびその製造方法ならびにマスク

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991052A (en) * 1975-07-18 1976-11-09 Eli Lilly And Company Antibiotic A-30641
US4001086A (en) * 1975-07-18 1977-01-04 Eli Lilly And Company Antibiotic a-30641 and process for production thereof
JP3383718B2 (ja) * 1995-02-15 2003-03-04 ニチモウ株式会社 大豆蛋白を原料とした生成物の製造方法

Also Published As

Publication number Publication date
ATE209493T1 (de) 2001-12-15
JP4287908B2 (ja) 2009-07-01
EP0914129A1 (de) 1999-05-12
CA2253635A1 (en) 1997-11-13
IL126548A0 (en) 1999-08-17
ES2163763T3 (es) 2002-02-01
EP0914129B1 (de) 2001-11-28
US6133254A (en) 2000-10-17
WO1997041862A1 (en) 1997-11-13
AU705290B2 (en) 1999-05-20
PT914129E (pt) 2002-04-29
DE69708645D1 (de) 2002-01-10
KR20000010724A (ko) 2000-02-25
DE69708645T2 (de) 2002-08-08
DK0914129T3 (da) 2002-01-28
CA2253635C (en) 2006-01-03
KR100439928B1 (ko) 2004-12-16
JP2000514403A (ja) 2000-10-31
AU2768497A (en) 1997-11-26

Similar Documents

Publication Publication Date Title
Sullivan Graft-vs-host disease
US5244896A (en) Carbocyclic adenosine analogs useful as immunosuppressants
Kim et al. Infection and cyclosporine
JP2005517637A (ja) 体外フォトフォレーシスおよび/またはアポプトーシス細胞による一定の被験体を前処理するための方法
FI102755B (fi) Menetelmä uuden, terapeuttisesti käyttökelpoisen yhdisteen tai sen suo lan valmistamiseksi
Gelfand et al. Partial purine nucleoside phosphorylase deficiency: studies of lymphocyte function
US5514688A (en) Carbocyclic adenosine analogs useful as immunosuppressants
Minagawa et al. Experimental allergic encephalomyelitis in the Lewis rat: a model of predictable relapse by cyclophosphamide
US5470857A (en) Carbocyclic nucleoside analogs useful as immunosuppressants
US6133254A (en) Use of aspirochlorine or derivatives thereof as immunosuppressive agents
Chen et al. Chronically HIV-1-infected monocytic cells induce apoptosis in cocultured T cells
WO2022235030A1 (ko) 면역 조절 분자가 풍부한 성숙 수지상 세포의 분화 방법
CA2044328A1 (en) Efomycins a.e. and g as antiinflammatory agents
NO305207B1 (no) Nye trans-syklopentanylpurinanaloger som er anvendbare som immunoundertrykkende midler
ARONSON Septicemia from Concomitant Infection with Trypanosoma Cruzi and Neisseria Perflava: First Case of Laboratory-acquired Chagas' Disease in the United States
US5453431A (en) Use of hydroxychloroquine for treatment of graft-versus-host disease
EP0475413B1 (de) Carbocyklische Nukleosidanaloge als Immunsuppressoren
Crow Enhancement of the impaired autologous mixed leukocyte reaction in patients with systemic lupus erythematosus.
CN116744913A (zh) 包含苯衍生物作为免疫抑制剂的免疫抑制药物组合物
Marcus et al. In vitro studies in reproductive immunology, 3. Restoration of mitogenic activity of lymphocytes inhibited by seminal plasma in man
CN120241739A (zh) Menin抑制剂BN104在制备预防和治疗移植物抗宿主病的应用
AU635857B2 (en) 5'-vinylhalo-aristeromycin/adenosine analogs as immunosuppressants
House et al. An in vitro study of renal allograft recipients for cellular delayed type hypersensitivity to glomerular basement membrane and disrupted spleen cells
Kitagami et al. Clonal analysis of antigen-specific interactions between T cells and genetically engineered B cells
Moynihan et al. Autoreactive T-cell response to resting or activated B cells

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired